Larvol Delta - AltruBio-Announces-Enrollment-of-First-Patient-in-Phase-2-Clinical-Program-of-ALTB268-for-the-Treatment-of-Ulcerative-Colitis

leiolizumab (ALTB-268) - AltruBio

https://www.globenewswire.com/news-release/2023/12/07/2792479/0/en/AltruBio-Announces-Enrollment-of-First-Patient-in-Phase-2-Clinical-Program-of-ALTB-268-for-the-Treatment-of-Ulcerative-Colitis.html

Dec 7, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next